Clinical Efficacy of Roxithromycin in the Treatment of Adults with Upper and Lower Respiratory Tract Infection Due to Haemophilus influenzae

12 clinical studies on the use of roxithromycin 300mg daily in adult respiratory tract infection were subject to meta-analysis. Nine of the studies were comparative and 5 were from the published literature. Auditable individual patient data were reviewed for 11 of the 12 studies.